VASCULAR BIOGENICS LTD ORD SHS (ISR)
VBLX
VBLX was delisted on the 7th of August, 2014.
0 hedge funds and large institutions have $0 invested in VASCULAR BIOGENICS LTD ORD SHS (ISR) in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $2.96M → $0 (-$2.96M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$2.96M |
VBLX Hedge Fund Activity: Q1 2015 in Review
0 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in VASCULAR BIOGENICS LTD ORD SHS (ISR) (VBLX) for Q1 2015, worth a combined $0 — down 100% from $2.96M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of VBLX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Perceptive Advisors, exiting entirely with an estimated $2.96M sold.
- 0 institutional investors held VASCULAR BIOGENICS LTD ORD SHS (ISR) (VBLX) as of Q1 2015, down from 1 in Q4 2014.
- Funds reported $0 of VASCULAR BIOGENICS LTD ORD SHS (ISR) stock for Q1 2015, down 100% quarter-over-quarter.
- 0 funds opened new VASCULAR BIOGENICS LTD ORD SHS (ISR) positions in Q1 2015 and 1 closed out, a net change of -1 holder.
- The largest VASCULAR BIOGENICS LTD ORD SHS (ISR) seller in Q1 2015 was Perceptive Advisors, an estimated $2.96M sold.
Based on aggregated 13F filings for Q1 2015.